Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env
|
journal
|
June 2015 |
Goniometer-based femtosecond crystallography with X-ray free electron lasers
|
journal
|
October 2014 |
Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans
|
journal
|
December 2015 |
Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site
|
journal
|
September 2016 |
Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody
|
journal
|
June 2017 |
Overview of the CCP 4 suite and current developments
|
journal
|
March 2011 |
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
|
journal
|
September 2014 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
|
text
|
January 2010 |
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
|
journal
|
April 2015 |
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
|
journal
|
October 2011 |
IOTA : integration optimization, triage and analysis tool for the processing of XFEL diffraction images
|
journal
|
May 2016 |
X-ray and EM structures of a natively glycosylated HIV-1 envelope trimer
|
journal
|
September 2017 |
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
|
journal
|
September 2013 |
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
|
journal
|
June 1998 |
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller
|
journal
|
January 2017 |
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
|
journal
|
May 2016 |
Intra-Spike Crosslinking Overcomes Antibody Evasion by HIV-1
|
journal
|
January 2015 |
Web servers and services for electrostatics calculations with APBS and PDB2PQR
|
journal
|
February 2011 |
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
|
text
|
January 2014 |
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
|
journal
|
October 2013 |
In situ click chemistry generation of cyclooxygenase-2 inhibitors
|
journal
|
February 2017 |
XDS
|
journal
|
January 2010 |
Inference of Macromolecular Assemblies from Crystalline State
|
journal
|
September 2007 |
Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike
|
journal
|
May 2014 |
Broad neutralization coverage of HIV by multiple highly potent antibodies
|
journal
|
September 2011 |
Few and Far Between: How HIV May Be Evading Antibody Avidity
|
journal
|
May 2010 |
Mass Spectrometric Characterization of the Glycosylation Pattern of HIV-gp120 Expressed in CHO Cells
|
journal
|
September 2000 |
Architecture of the synaptotagmin–SNARE machinery for neuronal exocytosis
|
journal
|
August 2015 |
Accurate macromolecular structures using minimal measurements from X-ray free-electron lasers
|
journal
|
March 2014 |
Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues
|
journal
|
June 2013 |
Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development
|
journal
|
September 2017 |
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
|
journal
|
March 2016 |
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
|
journal
|
July 2010 |
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
|
journal
|
May 2016 |
Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env
|
journal
|
September 2015 |
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
|
journal
|
November 2016 |
Electron Density Sharpening as a General Technique in Crystallographic Studies
|
journal
|
February 2014 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
|
journal
|
September 2016 |
Antibody neutralization and escape by HIV-1
|
journal
|
March 2003 |
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
|
journal
|
October 2012 |
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
|
journal
|
October 2013 |
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
|
journal
|
October 2013 |
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
|
journal
|
October 2011 |
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
|
journal
|
April 2017 |
Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies
|
journal
|
September 2014 |
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
|
journal
|
June 2012 |
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
|
journal
|
May 2013 |
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
|
journal
|
January 2017 |
A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans
|
journal
|
July 2016 |
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
|
journal
|
August 2011 |
Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers
|
journal
|
February 2017 |
Structural basis for germline gene usage of a potent class of antibodies targeting the CD4 binding site of HIV-1 gp120
|
journal
|
September 2012 |
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
|
journal
|
September 2016 |
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
|
journal
|
October 2012 |
Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies
|
journal
|
January 2014 |
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
|
journal
|
October 2014 |
Linking Crystallographic Model and Data Quality
|
journal
|
May 2012 |
Attosecond pulse retrieval from noisy streaking traces with conditional variational generative network
|
journal
|
April 2020 |
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer
|
journal
|
March 2016 |
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
|
journal
|
December 2015 |
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
|
journal
|
September 1998 |
Conformational exchange in the potassium channel blocker ShK
|
journal
|
December 2019 |
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
|
journal
|
May 2016 |
The HIV-1 envelope glycoprotein structure: nailing down a moving target
|
journal
|
January 2017 |
Model Building and Refinement of a Natively Glycosylated HIV-1 Env Protein by High-Resolution Cryoelectron Microscopy
|
journal
|
October 2015 |
PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome
|
journal
|
December 2019 |
Cavin1 intrinsically disordered domains are essential for fuzzy electrostatic interactions and caveola formation
|
journal
|
February 2021 |
Features and development of Coot
|
journal
|
March 2010 |
A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene
|
journal
|
January 2015 |
Antibody engineering for increased potency, breadth and half-life
|
journal
|
January 2015 |
Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope
|
journal
|
November 2014 |
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
|
journal
|
February 2014 |
Overview of the CCP4 suite and current developments.
|
text
|
January 2011 |
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
|
journal
|
March 2013 |
Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development
|
journal
|
November 2017 |
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies
|
journal
|
August 2013 |
Enabling X-ray free electron laser crystallography for challenging biological systems from a limited number of crystals
|
journal
|
March 2015 |
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
|
journal
|
September 2020 |
Role of Complex Carbohydrates in Human Immunodeficiency Virus Type 1 Infection and Resistance to Antibody Neutralization
|
journal
|
March 2010 |
Phaser crystallographic software
|
journal
|
July 2007 |
Programmable RNA targeting by bacterial Argonaute nucleases with unconventional guide binding and cleavage specificity
|
journal
|
August 2022 |
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
|
journal
|
September 2013 |